Metastatic basal cell carcinoma
Related Experiment Video
Updated: Sep 25, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Stephen Thomas Spates1, J Ramsey Mellette, James Fitzpatrick
1Department of Dermatology, Division of Cutaneous Surgery, University of Colorado Health Sciences Center, Aurora, Colorado, USA. stscolo@hotmail.com
Background:
Basal cell carcinoma is the most common malignancy of humans. Although it is axiomatic that this tumor does not evolve into metastatic disease, such events rarely occur, and this possibility should not be overlooked.
Objectives:
The reader should better understand the sequence of events that resulted in metastatic disease and how these events are emblematic of the rare cases of basal cell carcinoma that systemically spread.
Methods:
We present a case report of basal cell carcinoma that underwent distant metastasis. A short review of the literature is included.
Results:
Although basal cell carcinoma is commonly considered a regional tumor with virtually no propensity for distant spread, this case reveals that metastatic disease does occur and with devastating results.
Conclusion:
Metastatic disease in basal cell carcinoma is a very rare but catastrophic consequence of this very common skin malignancy.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...